Abstract
Growing evidence has shown that the proforms of several neurotrophins, e.g., nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin3 (NT3) can be synthesized, secreted from neurons or glial cells and function actively in mammalian nervous system. By the intracellular and extracellular enzymatic cleavage processing, mature neurotrophins are generated and exert their functions in the developing, physiological and pathological activities. While mature neurotrophins exhibit neuroprotective roles via tyrosine kinase receptors (TrkA, TrkB and TrkC), the proforms of neurotrophins show totally-different biological effects that may induce apoptotic cell death of neurons by triggering p75NTR-sortilin signaling cascades. In addition, another key neurotrophic factor named glial-derived neurotrophic factor (GDNF) also appears to be a product generated from proGDNF, and its cleavage and potential biological function of proGDNF remains an unrevealed problem. Obviously, accumulating studies indicated that the exact or timely cleavage processing should be essential for the functional switch from proneurotrophins to mature neurotrophins, while dysfunction in the enzymatic cleavage, aberrant extracellular release, and abnormal subunit organization of binding receptors might be also crucially involved in neurodegeneration of the central neurons, pathogenesis, and even disease progression of various neurodegenerative diseases in human beings.
Keywords: Neurotrophins, Neuroprotection, Proneurotrophins, Neurodegeneration, Neurodegenerative disease.
Current Protein & Peptide Science
Title:Functional Switch From Pro-Neurotrophins to Mature Neurotrophins
Volume: 14 Issue: 7
Author(s): Xiao-Long Sun, Bei-Yu Chen, Yi Xia, Jing-Jie Wang and Liang-Wei Chen
Affiliation:
Keywords: Neurotrophins, Neuroprotection, Proneurotrophins, Neurodegeneration, Neurodegenerative disease.
Abstract: Growing evidence has shown that the proforms of several neurotrophins, e.g., nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin3 (NT3) can be synthesized, secreted from neurons or glial cells and function actively in mammalian nervous system. By the intracellular and extracellular enzymatic cleavage processing, mature neurotrophins are generated and exert their functions in the developing, physiological and pathological activities. While mature neurotrophins exhibit neuroprotective roles via tyrosine kinase receptors (TrkA, TrkB and TrkC), the proforms of neurotrophins show totally-different biological effects that may induce apoptotic cell death of neurons by triggering p75NTR-sortilin signaling cascades. In addition, another key neurotrophic factor named glial-derived neurotrophic factor (GDNF) also appears to be a product generated from proGDNF, and its cleavage and potential biological function of proGDNF remains an unrevealed problem. Obviously, accumulating studies indicated that the exact or timely cleavage processing should be essential for the functional switch from proneurotrophins to mature neurotrophins, while dysfunction in the enzymatic cleavage, aberrant extracellular release, and abnormal subunit organization of binding receptors might be also crucially involved in neurodegeneration of the central neurons, pathogenesis, and even disease progression of various neurodegenerative diseases in human beings.
Export Options
About this article
Cite this article as:
Sun Xiao-Long, Chen Bei-Yu, Xia Yi, Wang Jing-Jie and Chen Liang-Wei, Functional Switch From Pro-Neurotrophins to Mature Neurotrophins, Current Protein & Peptide Science 2013; 14 (7) . https://dx.doi.org/10.2174/1389203711209070658
DOI https://dx.doi.org/10.2174/1389203711209070658 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
Call for Papers in Thematic Issues
Advancements in Proteomic and Peptidomic Approaches in Cancer Immunotherapy: Unveiling the Immune Microenvironment
The scope of this thematic issue centers on the integration of proteomic and peptidomic technologies into the field of cancer immunotherapy, with a particular emphasis on exploring the tumor immune microenvironment. This issue aims to gather contributions that illustrate the application of these advanced methodologies in unveiling the complex interplay ...read more
Artificial Intelligence for Protein Research
Protein research, essential for understanding biological processes and creating therapeutics, faces challenges due to the intricate nature of protein structures and functions. Traditional methods are limited in exploring the vast protein sequence space efficiently. Artificial intelligence (AI) and machine learning (ML) offer promising solutions by improving predictions and speeding up ...read more
Nutrition and Metabolism in Musculoskeletal Diseases
The musculoskeletal system consists mainly of cartilage, bone, muscles, tendons, connective tissue and ligaments. Balanced metabolism is of vital importance for the homeostasis of the musculoskeletal system. A series of musculoskeletal diseases (for example, sarcopenia, osteoporosis) are resulted from the dysregulated metabolism of the musculoskeletal system. Furthermore, metabolic diseases (such ...read more
Protein Folding, Aggregation and Liquid-Liquid Phase Separation
Protein folding, misfolding and aggregation remain one of the main problems of interdisciplinary science not only because many questions are still open, but also because they are important from the point of view of practical application. Protein aggregation and formation of fibrillar structures, for example, is a hallmark of a ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Missions for an Old Agent: Granulocyte-Colony Stimulating Factor in the Treatment of Stroke Patients
Current Medicinal Chemistry Enhancement of Solubility of Lutein by Solid Dispersion Technique and Development of its Stable Orodispersible Film Formulation
Current Drug Therapy Dimethyl Sulfoxide as an Excitatory Modulator and its Possible Role in Cancer Pain Management
Inflammation & Allergy - Drug Targets (Discontinued) Intestinal Immunomodulation. Role of Regulative Peptides and Promising Pharmacological Activities
Current Pharmaceutical Design Immunomodulatory Effects of <i>Allium sativum</i> L. and its Constituents against Viral Infections and Metabolic Diseases
Current Topics in Medicinal Chemistry Lipid Lowering Agents, Inflammation and Atherosclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Functional Selectivity in Cannabinoid Signaling
Current Molecular Pharmacology Phosphodiesterase as a New Therapeutic Target for the Treatment of Spinal Cord Injury and Neurodegenerative Diseases
Current Medicinal Chemistry The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
Current Drug Metabolism Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions
Current Drug Targets Area, Age and Gender Dependence of the Nucleoside System in the Brain: a Review of Current Literature
Current Topics in Medicinal Chemistry Cannabinoids, Immune System and Cytokine Network
Current Pharmaceutical Design Feasibility and Prospects for Anti-Inflammatory Antibodies in the Treatment and Disease Management of Influenza
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Editorial (Thematic Issue: Novel Insights into the Role of Anesthetics and Opioids in Organ or Tissue Protection)
Current Pharmaceutical Design Subject Index to Volume 2
Current Neuropharmacology Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Models and Multiple Sclerosis
Current Pharmaceutical Design The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders I: Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Effects of Melatonin on Peripheral Nerve Regeneration
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Vehicles for Lipophilic Drugs: Implications for Experimental Design, Neuroprotection, and Drug Discovery
Current Neurovascular Research Inflammation: Beneficial or Detrimental After Spinal Cord Injury?
Recent Patents on CNS Drug Discovery (Discontinued)